Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

(2013) S Döcke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome

(2013) Ishwarlal Jialal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes

(2013) Syeda Sadia Fatima et al.   PLoS One

Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism

(2012) Michiko Takahashi et al.   ENDOCRINE JOURNAL

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Chemerin as a Mediator between Obesity and Vascular Inflammation in Children

(2012) Kathrin Landgraf et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: Adipose depot specificity and gender dimorphism

(2012) Assim A. Alfadda et al.   MOLECULES AND CELLS

Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome

(2012) Sang Hui Chu et al.   PLoS One

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome

(2012) D. Margriet Ouwens et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Chemerin levels are positively correlated with abdominal visceral fat accumulation

(2011) Hyun-Young Shin et al.   CLINICAL ENDOCRINOLOGY

Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease

(2011) H. O. El-Mesallamy et al.   DIABETIC MEDICINE

Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome

(2011) Baokang Dong et al.   INTERNAL MEDICINE

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

(2011) Rima Chakaroun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Serum levels of the adipokine chemerin are increased in preeclampsia during and 6months after pregnancy

(2011) Holger Stepan et al.   REGULATORY PEPTIDES

Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients

(2011) Victoria Catalán et al.   Surgery for Obesity and Related Diseases

Chemerin regulates β-cell function in mice

(2011) Michiko Takahashi et al.   Scientific Reports

Insulin-sensitive obesity

(2010) Nora Klöting et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes

(2010) Matthew C. Ernst et al.   ENDOCRINOLOGY

Effect of bariatric surgery on circulating chemerin levels

(2010) C. Ress et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery

(2010) Henrike Sell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum chemerin and vaspin in non-alcoholic fatty liver disease

(2010) Michal Kukla et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

(2010) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Chemerin: at the crossroads of inflammation and obesity

(2010) Matthew C. Ernst et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Serum Levels of the Adipokine Chemerin in Relation to Renal Function

(2009) D. Pfau et al.   DIABETES CARE

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

(2009) Michael Lehrke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study

(2009) Adam G Tabák et al.   LANCET

Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro

(2009) Susan Kralisch et al.   REGULATORY PEPTIDES

Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: Tools or decorations?

(2009) Yusuf Yilmaz et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

(2008) Michiko Takahashi et al.   FEBS LETTERS

Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity

(2008) Enzo Emanuele   HEPATOLOGY

Chemerin reveals its chimeric nature: Figure 1.

(2008) Teizo Yoshimura et al.   JOURNAL OF EXPERIMENTAL MEDICINE